Regencell Bioscience Holdings Limited (RGC)

HK — Healthcare Sector
Peers: DLTNF  RAMMF  CVGRF  BHHKF  SPBBF  PROCW  SSIC  EGRX  PAHC  SBFMW  COSM  ACRX  HEXO  PBH  COLL  ANIP  PROC 

Automate Your Wheel Strategy on RGC

With Tiblio's Option Bot, you can configure your own wheel strategy including RGC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol RGC
  • Rev/Share 0.0
  • Book/Share 0.6316
  • PB 794.2271
  • Debt/Equity 0.0104
  • CurrentRatio 41.916
  • ROIC -0.2841

 

  • MktCap 6527530898.0
  • FreeCF/Share 0.0
  • PFCF 0.0
  • PE -2917.4995
  • Debt/Assets 0.0102
  • DivYield 0
  • ROE -0.2523

 

  • Rating
  • Score
  • Recommendation
  • P/E Score
  • DCF Score
  • P/B Score
  • D/E Score

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Regencell Bioscience Holdings Limited (RGC)

  • IPO Date 2021-07-16
  • Website https://www.regencellbioscience.com
  • Industry Drug Manufacturers - Specialty & Generic
  • CEO Mr. Yat-Gai Au
  • Employees 12
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.